9ÔÂ3ÈÕÍí¼ä£¬¿Æ´´°å¹«Ë¾Ö÷ÒªÐÂÎÅÈçÏ£º
ÕéÀؿƼ¼×îй«¸æ£ºÊµ¿ØÈË¡¢¶Ê³¤ÌáÒ黨¹º¹«Ë¾¹É·Ý
ÕéÀؿƼ¼¹«¸æ£¬¹«Ë¾Êµ¼Ê¿ØÖÆÈË¡¢¶Ê³¤Óô·¢ÐÂÌáÒ鹫˾ÒÔ¼¯Öоº¼Û½»Ò×·½Ê½»Ø¹º²¿·Ö¹«Ë¾ÒÑ·¢ÐеÄÈËÃñ±ÒÆÕͨ¹É£¨A¹É£©¹ÉƱ£¬ÔÚδÀ´ÊÊÒËʱ»ú½«Ç°Êö»Ø¹º¹É·ÝÓÃÓÚÔ±¹¤³Ö¹É¼Æ»®»ò¹ÉȨ¼¤Àø£¬ÒÔ¼°ÓÃÓÚά»¤¹«Ë¾¼ÛÖµ¼°¹É¶«È¨Òæ¡£»Ø¹º×ʽ𲻵ÍÓÚ2000ÍòÔª£¬²»³¬¹ý4000ÍòÔª¡£»Ø¹º¹É·Ý¼Û¸ñÉÏÏÞ²»¸ßÓÚ¶Ê»áÉóÒéͨ¹ý»Ø¹º·½°¸¾öÒéǰ30¸ö½»Ò×ÈÕ¹«Ë¾¹ÉƱ½»Ò×¾ù¼ÛµÄ150%¡£
ÆÕÔ´¾«µç×îй«¸æ£º¹«Ë¾Êµ¼Ê¿ØÖÆÈ˼°ÆäÒ»ÖÂÐж¯È˿عɱÈÀý±»¶¯Ï¡Êͳ¬¹ý1%
ÆÕÔ´¾«µç¹«¸æ£¬¹«Ë¾·¢ÐйɷݹºÂò±±¾©ÄÍÊýµç×ÓÓÐÏÞ¹«Ë¾67.7419%¹ÉȨµ¼ÖÂʵ¼Ê¿ØÖÆÈ˿عɱÈÀý±»¶¯Ï¡ÊͼõÉÙ£¬²»´¥¼°ÒªÔ¼ÊÕ¹º£¬²»»áµ¼Ö¹«Ë¾¿Ø¹É¹É¶«¼°Êµ¼Ê¿ØÖÆÈË·¢Éú±ä»¯¡£È¨Òæ±ä¶¯ºó£¬Êµ¼Ê¿ØÖÆÈËÍõÔü°ÆäÒ»ÖÂÐж¯È˺ϼƳÖÓй«Ë¾È¨ÒæµÄ¹É·ÝÊýΪ118400000¹É£¬Õ¼¹«Ë¾×ܹɱ¾µÄ±ÈÀýÓÉ63.96%±»¶¯Ï¡ÊÍÖÁ61.59%£¬³Ö¹É±ÈÀýºÏ¼Æ¼õÉÙ2.37%¡£
ʥŵÉúÎï×îй«¸æ£º¹É¶«ÀÖÆÕÒ½ÁÆÄâ¼õ³Ö²»³¬¹ý2%¹É·Ý
ʥŵÉúÎ﹫¸æ£¬¹«Ë¾¹É¶«ÀÖÆÕÒ½ÁÆÒò×ÔÉí×ʽðÐèÇ󣬼ƻ®Í¨¹ý¼¯Öоº¼ÛºÍ´ó×Ú½»Ò×·½Ê½¼õ³Ö²»³¬¹ý2%µÄ¹É·Ý£¬¼´²»³¬¹ý224Íò¹É¡£¼õ³ÖÆÚ¼äΪ2024Äê9ÔÂ27ÈÕÖÁ2024Äê12ÔÂ26ÈÕ¡£
ÈýÉú¹ú½¡×îй«¸æ£ºÊÕµ½²Î¹É¹«Ë¾·Öºì¿î6242.47ÍòÃÀÔª
ÈýÉú¹ú½¡¹«¸æ£¬¹«Ë¾³ÖÓвιɹ«Ë¾Numab Therapeutics AG 7.87%µÄ¹É·Ý¡£¸ù¾ÝNumabÒ»ÏîÓëÆä×Ó¹«Ë¾ÓйصÄÌØ±ð¹É¶«¾öÒ飬NumabÏòÆä¹É¶«½øÐÐÁËÌØ±ð¹ÉÏ¢·ÖÅ䣬¹«Ë¾ÊÕµ½6242.47ÍòÃÀÔª¡£¸ù¾ÝÏà¹Ø»á¼Æ×¼Ôò£¬ÉÏÊö·Öºì¿î¼ÆÈ빫˾2024Äê¶ÈËðÒæ£¬¶Ô¹«Ë¾2024Äê¶È¾ÓªÒµ¼¨²úÉú»ý¼«Ó°Ïì¡£
ºèȪÎïÁª×îй«¸æ£ºÀÛ¼ÆÊÕµ½»òÈ·ÈÏÕþ¸®²¹Öú¿îÏî808.34ÍòÔª
ºèȪÎïÁª¹«¸æ£¬¹«Ë¾¼°×Ó¹«Ë¾×Ô2024Äê1ÔÂ1ÈÕÖÁ2024Äê9ÔÂ3ÈÕ£¬ÀÛ¼ÆÊÕµ½»òÈ·ÈÏÕþ¸®²¹Öú¿îÏîÈËÃñ±Ò808.34ÍòÔª£¬¾ùΪÓëÊÕÒæÏà¹ØµÄÕþ¸®²¹Öú¿îÏî¡£ÉÏÊöÊÕµ½»òÈ·ÈϵÄÕþ¸®²¹Öú¶Ô¹«Ë¾2024Äê¶ÈÀûÈó²úÉúÒ»¶¨»ý¼«Ó°Ïì¡£¾ßÌåµÄ»á¼Æ´¦Àí¼°¶Ô¹«Ë¾2024Äê¶ÈËðÒæµÄÓ°ÏìÇé¿öÈÔÐëÒÔ»á¼ÆÊ¦Äê¶ÈÉó¼ÆÈ·ÈϺóµÄ½á¹ûΪ׼¡£
£¨ÑÇ»ãÍø±à¼£º±ù·²£©